Mar 2, 2026 06:01AM
Mar 2, 2026 02:00AM
Feb 19, 2026 12:00PM
Feb 19, 2026 12:00PM
Feb 10, 2026 04:50AM
Feb 10, 2026 03:15AM
Jan 29, 2026 01:37AM Takeda Reports Third-Quarter FY2025 Results: Updates Full Year Outlook to Reflect VYVANSE® Generics Impact, OPEX Discipline and FX Tailwind; Progressing Toward Three Transformative Launches Ahead
Jan 22, 2026 07:45AM
Jan 22, 2026 07:45AM
Jan 14, 2026 09:00AM
Jan 5, 2026 07:03AM
Jan 5, 2026 07:00AM
Dec 18, 2025 03:00AM
Dec 18, 2025 03:00AM Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment
Dec 8, 2025 02:54AM
Dec 6, 2025 09:30AM
Nov 7, 2025 11:01AM
Nov 7, 2025 11:00AM
Nov 3, 2025 08:33AM
Nov 3, 2025 07:00AM
Oct 30, 2025 03:04AM Takeda Reports First Half FY2025 Results, with Business Fundamentals Tracking as Planned. Updates Full Year Outlook to Reflect FX Impact and Pipeline Impairment. On Track for Multiple Regulatory Filin
Oct 27, 2025 08:35AM
Oct 21, 2025 08:25PM
Oct 21, 2025 08:25PM
Sep 23, 2025 06:04PM
Sep 16, 2025 08:02AM
Sep 16, 2025 08:00AM
Sep 11, 2025 08:45AM Takeda names Rhonda Pacheco as U.S. business unit president
Sep 11, 2025 08:45AM
Sep 8, 2025 03:00AM
Sep 8, 2025 03:00AM
Sep 5, 2025 08:45PM
Sep 5, 2025 08:45PM
Jul 30, 2025 02:41AM
Jul 21, 2025 08:01AM Takeda receives FDA clearance for HYQVIA administration devices
Jul 21, 2025 08:00AM
Jul 14, 2025 05:55AM
Jul 14, 2025 03:00AM
Jun 30, 2025 08:00AM
Jun 25, 2025 03:07AM
Jun 3, 2025 10:13AM
Jun 3, 2025 10:12AM European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD
Jun 1, 2025 08:00AM
May 27, 2025 07:30AM
May 14, 2025 05:10PM
May 14, 2025 05:03PM
May 8, 2025 02:36AM
May 5, 2025 08:00AM
Mar 3, 2025 06:46AM Protagonist Therapeutics (PTGX) and Takeda (TAK) Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Mar 3, 2025 06:45AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All